Webinar No. 3: IMMray™ PanCan-d Verification study and Clinical Use
Presentations by: Thomas King, MD, PhD, Linda Mellby, PhD, Laura Chirica, PhD, Immunovia
Moderator: Patrik Dahlen, CEO Immunovia
Immunovia interview with Prof. Stephen Pereira, Gastroenterologist and Hepatologist, BSc, PhD, FRCP, FRCPE, at the London Clinic (UCL), Principle Investigator for Immunovia´s PanSYM study in London, UK, in regard to the clinical utility of diagnostic tests in pancreatic cancer, December 8, 2020.
0:00 Introduction and Agenda 1:40 Positioning of IMMray™ PanCan-d in clinical practice 17:45 Verification study vs clinical practice 26:55 Voice of pancreatic cancer experts about IMMray™ PanCan-d clinical utility 41:22 Q&A Session
